RT @grumpeoldman: Government still flogging HCQS? Despite knowing that it doesn’t protect against COVID and causes irreversible damage ? ht…
RT @MathieuMolimard: Une étude randomisée contrôlée contre placebo supplémentaire https://t.co/IpRx73bSxW Pas de protection par #hydroxy…
Shout out to my mom @traumarhonda for participating in this important @PennMedicine study 👩🏻⚕️
@rabois The evidence is still coming in and trending toward negative for HCQ
No sirvió para prevenir Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial | Infectious Diseases | JAMA Internal Medicine | JAMA Network https://t.co/KsGAmzkBg
RT @TimLaheyMD: Another negative HCQ trial, this time as pre-exposure prophylaxis in HCW https://t.co/JcJQZyN1hD
RT @giordanopg: ¿Ya? ¿Ahora sí ya van a dejar de recetarla?
RT @TimLaheyMD: Another negative HCQ trial, this time as pre-exposure prophylaxis in HCW https://t.co/JcJQZyN1hD
RT @StephaneG05: No clinical benefit of hydroxychloroquine administered daily for 8 weeks as pre-exposure prophylaxis but adverse events mo…
RT @BleibtreuAlexa1: #HCQDIDNOTWORKS Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among He…
RT @BleibtreuAlexa1: #HCQDIDNOTWORKS Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among He…
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
See also here https://t.co/zdgwkD24oo
New study examining if #hydroxychloroquine can be used as a prophylaxis in health care workers found there was not a significant difference between it and placebo. https://t.co/6xSedWfhjW
RT @josegallucci: 👉 HCQ com mais um RCT negativo publicado. Um recorde de RCTs negativos. Efficacy and Safety of Hydroxychloroquine vs Plac…
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
RT @TimLaheyMD: Another negative HCQ trial, this time as pre-exposure prophylaxis in HCW https://t.co/JcJQZyN1hD
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial | Infectious Diseases | JAMA Internal Medicine | JAMA Network https://t.co/OZiJazVlQf
RT @ryoma_tanaka: 病院で勤務する医療従事者が、コロナウィルス感染予防のためにヒドロキシクロロキンを服用しても、効果はないっぽいです、という研究。 当初はかなりもてはやされましたが、治療でも予防でも、SARS-CoV-2関係でこの薬の名前を聞く機会は、めっきり…
RT @WesElyMD: Have you ever seen 👀 this before? JAMA on Hydroxychloroquine…The P-value here is GREATER THAN 0.99. Ahem, this stuff doesn’…
RT @TimLaheyMD: Another negative HCQ trial, this time as pre-exposure prophylaxis in HCW https://t.co/JcJQZyN1hD
RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
RT @mvholmes: Here's @_MiguelHernan 's analysis of HCQ as Covid19 prophylaxis updated with yesterday's trial (Abella et al https://t.co/mry…
Another negative HCQ trial, this time as pre-exposure prophylaxis in HCW https://t.co/JcJQZyN1hD
RT @josegallucci: 👉 HCQ com mais um RCT negativo publicado. Um recorde de RCTs negativos. Efficacy and Safety of Hydroxychloroquine vs Plac…
RT @MJA_Editor: Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co/YbF0FaxbrG via @JAM…
RT @josegallucci: 👉 HCQ com mais um RCT negativo publicado. Um recorde de RCTs negativos. Efficacy and Safety of Hydroxychloroquine vs Plac…
RT @FarmaMadridAP: (JAMA) Hidroxicloroquina en profilaxis pre-exposición entre los trabajadores de la salud de los hospitales: no previno l…
RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
RT @josegallucci: 👉 HCQ com mais um RCT negativo publicado. Um recorde de RCTs negativos. Efficacy and Safety of Hydroxychloroquine vs Plac…
RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
RT @mvholmes: Here's @_MiguelHernan 's analysis of HCQ as Covid19 prophylaxis updated with yesterday's trial (Abella et al https://t.co/mry…
RT @josegallucci: 👉 HCQ com mais um RCT negativo publicado. Um recorde de RCTs negativos. Efficacy and Safety of Hydroxychloroquine vs Plac…
RT @vbaosv: Confirmado. La hidroxicloroquina no sirve en profilaxis. https://t.co/dZv9Hkcv66
@alephh There is a new one to include: https://t.co/HPKuIWvc7Z
RT @FarmaMadridAP: (JAMA) Hidroxicloroquina en profilaxis pre-exposición entre los trabajadores de la salud de los hospitales: no previno l…
RT @Mumon89: #Idrossiclorochina si o no? La risposta (di nuovo) è no. Lo studio pubblicato su @JAMAInternalMed parla chiaro:assumere idross…
RT @vbaosv: Confirmado. La hidroxicloroquina no sirve en profilaxis. https://t.co/dZv9Hkcv66
RT @jameshamblin: Another clinical trial of hydroxychloroquine shows no benefit over placebo https://t.co/VsqZC40UqC
RT @FarmaMadridAP: (JAMA) Hidroxicloroquina en profilaxis pre-exposición entre los trabajadores de la salud de los hospitales: no previno l…
RT @derickwaderehab: Trump is not always factually correct. Hydroxychloroquine does not have a detectable benefit in preventing development…
@a_1_0_2 @MarcoSokolov @matthieugarby @TRACEYBTHIERRY @YanisJGR Pour vous faire _vraiment_ plaisir il y a ça aujourd'hui https://t.co/zVkNaquF45
#Idrossiclorochina si o no? La risposta (di nuovo) è no. Lo studio pubblicato su @JAMAInternalMed parla chiaro:assumere idrossiclorochina per evitare di essere infettati da #SARSCoV2 è pari al pasteggiare con delle caramelle alla frutta.#ScienceTwitter htt
RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
RT @mvholmes: Here's @_MiguelHernan 's analysis of HCQ as Covid19 prophylaxis updated with yesterday's trial (Abella et al https://t.co/mry…
RT @josegallucci: 👉 HCQ com mais um RCT negativo publicado. Um recorde de RCTs negativos. Efficacy and Safety of Hydroxychloroquine vs Plac…
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
RT @gkierzek: Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care...Bon, en prév…
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
Mas, olha... quem conseguiria imaginar um resultado desses?? Atenção: contém ironia!!!
RT @vbaosv: Confirmado. La hidroxicloroquina no sirve en profilaxis. https://t.co/dZv9Hkcv66
RT @MathieuMolimard: Une étude randomisée contrôlée contre placebo supplémentaire https://t.co/IpRx73bSxW Pas de protection par #hydroxy…
RT @josegallucci: 👉 HCQ com mais um RCT negativo publicado. Um recorde de RCTs negativos. Efficacy and Safety of Hydroxychloroquine vs Plac…
RT @josegallucci: 👉 HCQ com mais um RCT negativo publicado. Um recorde de RCTs negativos. Efficacy and Safety of Hydroxychloroquine vs Plac…
Here's @_MiguelHernan 's analysis of HCQ as Covid19 prophylaxis updated with yesterday's trial (Abella et al https://t.co/mryNmjGn2x) A neat example of why terminating trials early for futility adds v little information (👀 that SE) Same message as yester
Confirmado. La hidroxicloroquina no sirve en profilaxis. https://t.co/dZv9Hkcv66
RT @ADesaiMD: #COVID19 "Efficacy and Safety of #HCQ for Pre-exposure SARS-CoV-2 Prophylaxis Among #HCWs" [Sep 30, 20] @JAMAInternalMed http…
RT @gkierzek: Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care...Bon, en prév…
RT @gkierzek: Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care...Bon, en prév…
RT @StephaneG05: No clinical benefit of hydroxychloroquine administered daily for 8 weeks as pre-exposure prophylaxis but adverse events mo…
RT @gkierzek: Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care...Bon, en prév…
RT @gkierzek: Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care...Bon, en prév…
RT @gkierzek: Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care...Bon, en prév…
RT @gkierzek: Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care...Bon, en prév…
RT @MathieuMolimard: Une étude randomisée contrôlée contre placebo supplémentaire https://t.co/IpRx73bSxW Pas de protection par #hydroxy…
La 8’ ?
@Roxytonin Looks like there's data from another trial to add to the m-a https://t.co/mryNmjGn2x
RT @MathieuMolimard: Une étude randomisée contrôlée contre placebo supplémentaire https://t.co/IpRx73bSxW Pas de protection par #hydroxy…
RT @gbiondizoccai: Anyone surprised that #hydroxychloroquine is not useful as a preventive strategy againts #Covid_19? I guess not... Anyho…
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care...Bon, en préventif, donc tôt, ça n'a pas l'air de fonctionner https://t.co/h3HxDAPn0x via @JAMAInternalMed part of @JAMANetwork
RT @EJohnWherry: Even prophylactic HCQ does not work. Randomized trial by B.Abella & R.Amaravadi. Definitive answer. Efficacy and Safety of…
Anyone surprised that #hydroxychloroquine is not useful as a preventive strategy againts #Covid_19? I guess not... Anyhow, have a look at Abella et al, in @JAMAInternalMed https://t.co/tD7GY4gGQv https://t.co/clKTgTzAmv
RT @ryoma_tanaka: 病院で勤務する医療従事者が、コロナウィルス感染予防のためにヒドロキシクロロキンを服用しても、効果はないっぽいです、という研究。 当初はかなりもてはやされましたが、治療でも予防でも、SARS-CoV-2関係でこの薬の名前を聞く機会は、めっきり…
RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
#HCQDIDNOTWORKS Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co/YpEfcdGGO8 via @JAMAInternalMed part of @JAMANetwork @SPILF_ @nathanpsmad @ReJIF_
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
RT @FarmaMadridAP: (JAMA) Hidroxicloroquina en profilaxis pre-exposición entre los trabajadores de la salud de los hospitales: no previno l…
Yet another piece of evidence indicating that #Hydroxychloroquine does not help in the prevention of #SARSCoV2 infection. Given the cumulative scientific evidence that exists, I'm just wondering if conducting more research work on this very subject is now
RT @GIPEIT: ¿HCQ como profilaxis? Tampoco funciona. https://t.co/qs38ycIr8p
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
RT @AdanZBecerra1: @_MiguelHernan @NoahHaber Miguel, perhaps you can update the meta analysis with these results? https://t.co/SoLxbYSkYH
RT @MJA_Editor: Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co/YbF0FaxbrG via @JAM…
RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
No habría beneficio clínico de la administración diaria de hidroxicloroquina por 8 sem como profilaxis prexposición en los trabajadores sanitarios hospitalarios expuestos a pacientes con COVID https://t.co/oZc2iZYjim a través de @JAMAInternalMed part of @J
RT @StephaneG05: No clinical benefit of hydroxychloroquine administered daily for 8 weeks as pre-exposure prophylaxis but adverse events mo…
RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
RT @Coxigru: On finira par comprendre? Non seulement inefficace mais dangereux! https://t.co/iZvJKfHNnX
On finira par comprendre? Non seulement inefficace mais dangereux!
RT @giordanopg: ¿Ya? ¿Ahora sí ya van a dejar de recetarla?
RT @fjcarrascos: No aporta beneficios en sanitarios preexposicion Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SAR…
RT @StephaneG05: No clinical benefit of hydroxychloroquine administered daily for 8 weeks as pre-exposure prophylaxis but adverse events mo…